Literature DB >> 20734176

Depressive mood is associated with ataxic and non-ataxic neurological dysfunction in SCA3 patients.

Jonas Alex Morales Saute, Andrew Chaves Feitosa da Silva, Karina Carvalho Donis, Leonardo Vedolin, Maria Luiza Saraiva-Pereira, Laura Bannach Jardim.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20734176     DOI： 10.1007/s12311-010-0205-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN： 1473-4222            Impact factor:   3.847


× No keyword cloud information.
  11 in total

1.  Self-rated health status in spinocerebellar ataxia--results from a European multicenter study.

Authors:  Tanja Schmitz-Hübsch; Mathieu Coudert; Paola Giunti; Christoph Globas; Laszlo Baliko; Roberto Fancellu; Caterina Mariotti; Alessandro Filla; Maryla Rakowicz; Perrine Charles; Pascale Ribai; Sandra Szymanski; Jon Infante; Bart P C van de Warrenburg; Alexandra Dürr; Dagmar Timmann; Sylvia Boesch; Rafal Rola; Chantal Depondt; Ludger Schöls; Elszbieta Zdzienicka; Jun-Suk Kang; Susanne Ratzka; Berry Kremer; Jörg B Schulz; Thomas Klopstock; Bela Melegh; Sophie Tezenas du Montcel; Thomas Klockgether
Journal:  Mov Disord       Date:  2010-04-15       Impact factor: 10.338

2.  Fluorescent multiplex PCR--fast method for autosomal dominant spinocerebellar ataxias screening.

Authors:  P O Bauer; S E Kotliarova; V Matoska; Z Musova; P Hedvicakova; A Boday; A Tomek; N Nukina; P Goetz
Journal:  Genetika       Date:  2005-06

3.  Scale for the assessment and rating of ataxia: development of a new clinical scale.

Authors:  T Schmitz-Hübsch; S Tezenas du Montcel; L Baliko; J Berciano; S Boesch; C Depondt; P Giunti; C Globas; J Infante; J-S Kang; B Kremer; C Mariotti; B Melegh; M Pandolfo; M Rakowicz; P Ribai; R Rola; L Schöls; S Szymanski; B P van de Warrenburg; A Dürr; T Klockgether; Roberto Fancellu
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

4.  Occupational therapy in spinocerebellar ataxia type 3: an open-label trial.

Authors:  R C R Silva; J A M Saute; A C F Silva; A C O Coutinho; M L Saraiva-Pereira; L B Jardim
Journal:  Braz J Med Biol Res       Date:  2010-04-16       Impact factor: 2.590

5.  Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives.

Authors:  C R Cecchin; A P Pires; C R Rieder; T L Monte; I Silveira; T Carvalho; M L Saraiva-Pereira; J Sequeiros; L B Jardim
Journal:  Community Genet       Date:  2007

6.  Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

Authors:  Ina Klinke; Martina Minnerop; Tanja Schmitz-Hübsch; Marc Hendriks; Thomas Klockgether; Ullrich Wüllner; Christoph Helmstaedter
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

7.  Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings.

Authors:  L Vedolin; I V D Schwartz; M Komlos; A Schuch; A C Azevedo; T Vieira; F K Maeda; A M Marques da Silva; R Giugliani
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

8.  A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3).

Authors:  C Kieling; C R M Rieder; A C F Silva; J A M Saute; C R Cecchin; T L Monte; L B Jardim
Journal:  Eur J Neurol       Date:  2008-02-26       Impact factor: 6.089

Review 9.  New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Udo Rüb; Ewout R Brunt; Thomas Deller
Journal:  Curr Opin Neurol       Date:  2008-04       Impact factor: 5.710

10.  Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects.

Authors:  C Gorenstein; L Andrade
Journal:  Braz J Med Biol Res       Date:  1996-04       Impact factor: 2.590
View more
  7 in total

1.  Sleep disorders in machado-joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-related motor and non-motor features.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; André Carvalho Felício; Lívia Almeida Dutra; William A C Santos; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

2.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

Review 3.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 4.  Nonmotor symptoms in spinocerebellar ataxias (SCAs).

Authors:  Adriana Moro; Mariana Moscovich; Marina Farah; Carlos Henrique F Camargo; Hélio A G Teive; Renato P Munhoz
Journal:  Cerebellum Ataxias       Date:  2019-08-27

Review 5.  Neurocognitive Changes in Spinocerebellar Ataxia Type 3: A Systematic Review with a Narrative Design.

Authors:  Kah Hui Yap; Roy P C Kessels; Shahrul Azmin; Bart van de Warrenburg; Norlinah Mohamed Ibrahim
Journal:  Cerebellum       Date:  2021-07-07       Impact factor: 3.648

6.  Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease.

Authors:  Yanetza González-Zaldívar; Yaimeé Vázquez-Mojena; José M Laffita-Mesa; Luis E Almaguer-Mederos; Roberto Rodríguez-Labrada; Gilberto Sánchez-Cruz; Raúl Aguilera-Rodríguez; Tania Cruz-Mariño; Nalia Canales-Ochoa; Patrick MacLeod; Luis Velázquez-Pérez
Journal:  Cerebellum Ataxias       Date:  2015-02-21

7.  Discordance Between Patient-Reported Outcomes and Physician-Rated Motor Symptom Severity in Early-to-Middle-Stage Spinocerebellar Ataxia Type 3.

Authors:  Roderick P P W M Maas; Dennis J L G Schutter; Bart P C van de Warrenburg
Journal:  Cerebellum       Date:  2021-03-10       Impact factor: 3.847
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.